Team:Washington/Gram Negative

From 2010.igem.org

(Difference between revisions)
(Type VI Secretion)
(The T6SS/Tse2 System)
Line 28: Line 28:
[[Image: Washington Get away.jpg]]
[[Image: Washington Get away.jpg]]
=The T6SS/Tse2 System=
=The T6SS/Tse2 System=
-
Our plan is to turn the Type 6 Secretion System (T6SS)/Tse2 from ''Pseudomonas aeruginosa'' into a targeted antibiotic suitable for use in ''E. coli''. The T6SS is a 22 protein complex found in many gram-negative species ( including ''P. aeruginosa'', but not ''E. coli''). The T6SS acts much like a spear, physically puncturing the cell membrane of the target cell and providing a channel through which proteins can be secreted. In ''P. aeruginosa'', one of the major substrates of the T6SS is the toxic protein Tse2 (Type Six Excreted 2). Normally, Tse2 forms a complex with Tsi2 ( Type Six Immunity 2), a protein co-expressed with Tse2 that  acts as an antitoxin. Before secrfetion of Tse2, Tsi2 dissociates from Tse2. Tse2 is then secreted into the target cell by the T6SS, killing the target cell.
+
Our plan is to turn the Type VI Secretion System (T6SS)/Tse2 from ''Pseudomonas aeruginosa'' into a targeted antibiotic suitable for use in ''E. coli''. The T6SS is a 22 protein complex found in many gram-negative species ( including ''P. aeruginosa'', but not ''E. coli''). The T6SS acts much like a spear, physically puncturing the cell membrane of the target cell and providing a channel through which proteins can be secreted. In ''P. aeruginosa'', one of the major substrates of the T6SS is the toxic protein Tse2 (Type Six Excreted 2). Normally, Tse2 forms a complex with Tsi2 ( Type Six Immunity 2), a protein co-expressed with Tse2 that  acts as an antitoxin. Before secrfetion of Tse2, Tsi2 dissociates from Tse2. Tse2 is then secreted into the target cell by the T6SS, killing the target cell.
=Regulating the Probiotic=
=Regulating the Probiotic=

Revision as of 03:34, 9 October 2010

Probiotics in a Gram-Negative Organism

Washington Get away.jpg

The T6SS/Tse2 System

Our plan is to turn the Type VI Secretion System (T6SS)/Tse2 from Pseudomonas aeruginosa into a targeted antibiotic suitable for use in E. coli. The T6SS is a 22 protein complex found in many gram-negative species ( including P. aeruginosa, but not E. coli). The T6SS acts much like a spear, physically puncturing the cell membrane of the target cell and providing a channel through which proteins can be secreted. In P. aeruginosa, one of the major substrates of the T6SS is the toxic protein Tse2 (Type Six Excreted 2). Normally, Tse2 forms a complex with Tsi2 ( Type Six Immunity 2), a protein co-expressed with Tse2 that acts as an antitoxin. Before secrfetion of Tse2, Tsi2 dissociates from Tse2. Tse2 is then secreted into the target cell by the T6SS, killing the target cell.

Regulating the Probiotic

One of the goals of this project is to regulate the Tse2/Tsi2 locus so that the probiotic only kills cells when a pathogen is present. This would require a promoter that is induced by an excreted molecule unique to a specific pathogenic gram-negative species. As a proof of concept, this project uses the LuxR-pLux transcription factor- promoter system from Vibrio fischeri to regulate expression of the Tse2-Tsi2 locus. V. fischeri excretes 3OC6HSL, a small cell membrane permiable molecule. 3OC6HSL binds to LuxR, chnaging the conformation of LuxR, resulting in expression from the pLux promoter. Since V. fischeri also produces 3OC6HSL, expression from the pLux promoter is linked to cell density. This is refered to as quorum sensing. Quorum sensing is found in many pathogenic species, making the use of the pLux-LuxR system a good proof-of concept. When our probiotic detects a gram-negative pathogen-specific molecule ( modeled by 3OC6HSL), transcription is induced from an inducable promoter( modeled by pLux). This leads to expression of Tse2 ( a toxic protein) and Tsi2 ( its antitoxin). The Type 6 Secretion System then attacks the pathogen, puncturing the cell wall. Tse2 is then secreted into the gram - pathogen, killing the pathogen.

Type VI Secretion

Washington T6SS Intro.jpg


Testing the Gram(+) Therapeutic       Designing the Gram(-) Therapeutic